HK1013594A1 - Generation of human insulin - Google Patents

Generation of human insulin

Info

Publication number
HK1013594A1
HK1013594A1 HK98110997A HK98110997A HK1013594A1 HK 1013594 A1 HK1013594 A1 HK 1013594A1 HK 98110997 A HK98110997 A HK 98110997A HK 98110997 A HK98110997 A HK 98110997A HK 1013594 A1 HK1013594 A1 HK 1013594A1
Authority
HK
Hong Kong
Prior art keywords
human insulin
generation
folded
polypeptide
new
Prior art date
Application number
HK98110997A
Other languages
English (en)
Inventor
Jacob R Hartman
Simona Mendelovitz
Marian Gorecki
Original Assignee
Savient Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22243290&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1013594(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Savient Pharmaceuticals Inc filed Critical Savient Pharmaceuticals Inc
Publication of HK1013594A1 publication Critical patent/HK1013594A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
HK98110997A 1994-12-29 1998-09-26 Generation of human insulin HK1013594A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/013268 WO1996020724A1 (en) 1994-12-29 1994-12-29 Generation of human insulin

Publications (1)

Publication Number Publication Date
HK1013594A1 true HK1013594A1 (en) 1999-09-03

Family

ID=22243290

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110997A HK1013594A1 (en) 1994-12-29 1998-09-26 Generation of human insulin

Country Status (16)

Country Link
EP (1) EP0871474B2 (es)
JP (1) JP4624495B2 (es)
AT (1) ATE350053T1 (es)
AU (1) AU698872B2 (es)
BR (1) BR9408638A (es)
CA (1) CA2208095C (es)
CZ (1) CZ290079B6 (es)
DE (2) DE69434909T3 (es)
DK (1) DK0871474T4 (es)
ES (1) ES2279510T5 (es)
HK (1) HK1013594A1 (es)
HU (1) HU223718B1 (es)
NZ (1) NZ279002A (es)
PL (1) PL180818B1 (es)
PT (1) PT871474E (es)
WO (1) WO1996020724A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
MXPA00009564A (es) * 1998-03-31 2004-03-10 Thongua Gantech Biotechnology Proteina quimerica que contiene una secuencia similar a la caperona intramolecular y su aplicacion a la produccion de insulina.
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
JP2003528149A (ja) 2000-03-24 2003-09-24 ジェネンテック・インコーポレーテッド 軟骨性疾患の治療のためのインスリンの使用
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
JP2004536018A (ja) 2000-07-31 2004-12-02 バル・イラン・ユニバーシティ 創傷治療のための方法および薬学的組成物
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
DE602004014251D1 (de) 2003-01-31 2008-07-17 Organon Nv Verfahren zur proteinisolierung unteranoxischen bedingungen
CN102120031B (zh) 2003-08-07 2012-12-05 希尔洛有限公司 用于加速伤口愈合的药物组合物和方法
US9074015B2 (en) * 2010-07-28 2015-07-07 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
WO2012048856A1 (en) 2010-10-12 2012-04-19 Glucometrix Pvs Gmbh Proinsulin with helper sequence
WO2012098009A1 (en) 2011-01-21 2012-07-26 Glucometrix Ag Chimeric polypeptide comprising a membrane protein and an insulin precursor
WO2013149729A2 (en) 2012-04-04 2013-10-10 Glucometrix Ag Proinsulin with enhanced helper sequence
CA2866491A1 (en) * 2014-10-02 2016-04-02 Clay Purdy Synthetic acid compositions and uses thereof
JP2018531007A (ja) * 2015-09-24 2018-10-25 ハンミ ファーマシューティカル カンパニー リミテッド インスリンの製造方法
PL239062B1 (pl) * 2016-01-22 2021-11-02 Inst Biotechnologii I Antybiotykow Sposób wytwarzania insuliny i jej pochodnych
KR20190043609A (ko) 2016-09-06 2019-04-26 케미컬 앤드 바이오파마슈티컬 라보라토리즈 오브 파트라스 에스.에이. 프로인슐린 유도체
US20210230659A1 (en) * 2018-06-18 2021-07-29 Unichem Laboratories Ltd Leader Sequence for Higher Expression of Recombinant Proteins
WO2020051812A1 (zh) * 2018-09-12 2020-03-19 美药星（南京）制药有限公司 一种新型门冬胰岛素原的结构和制备门冬胰岛素的方法
WO2020069040A1 (en) 2018-09-25 2020-04-02 Amphastar Pharmaceuticals, Inc. Highly purified recombinant human insulin (rhi) api and methods of producing the same
CN113527505A (zh) * 2020-04-15 2021-10-22 博锐生物科技有限公司 一种多肽和包含该多肽的药物组合物以及它们的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
US5342921A (en) * 1985-03-28 1994-08-30 Chiron Corporation Superoxide dismutase fusion polypeptides for expression of mammalian proteins
DE3679343D1 (de) † 1985-03-28 1991-06-27 Chiron Corp Expression durch verwendung von fusionsgenen fuer proteinproduktion.
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
IL104727A (en) * 1992-02-18 1997-01-10 Lilly Co Eli Selective removal of n-terminal extensions from folded insulin precursors using dipeptidyl-aminopeptidase-1
DE19701167A1 (de) * 1997-01-15 1998-07-23 Siemens Ag Chipkarte

Also Published As

Publication number Publication date
EP0871474B2 (en) 2011-09-21
CZ290079B6 (cs) 2002-05-15
ATE350053T1 (de) 2007-01-15
DK0871474T4 (da) 2012-01-09
CA2208095A1 (en) 1996-07-11
PT871474E (pt) 2007-02-28
CZ203197A3 (cs) 1998-09-16
JPH10511849A (ja) 1998-11-17
JP4624495B2 (ja) 2011-02-02
ES2279510T3 (es) 2007-08-16
HUT78070A (hu) 1999-08-30
BR9408638A (pt) 2004-09-21
HU223718B1 (hu) 2004-12-28
EP0871474A1 (en) 1998-10-21
WO1996020724A1 (en) 1996-07-11
CA2208095C (en) 2006-11-28
DE95907193T1 (de) 2005-02-10
DE69434909T2 (de) 2007-08-09
DK0871474T3 (da) 2007-05-07
EP0871474A4 (en) 2004-08-18
DE69434909T3 (de) 2012-02-09
PL180818B1 (pl) 2001-04-30
EP0871474B1 (en) 2007-01-03
PL321039A1 (en) 1997-11-24
AU698872B2 (en) 1998-11-12
ES2279510T5 (es) 2012-01-19
NZ279002A (en) 1999-02-25
AU1550095A (en) 1996-07-24
DE69434909D1 (de) 2007-02-15

Similar Documents

Publication Publication Date Title
HK1013594A1 (en) Generation of human insulin
HK1049022A1 (zh) 生產hcv包膜蛋白的重組
HU902697D0 (en) Process for the enzymatic removal of the n-terminal sequence of proteins
EP0542863A4 (en) Expression of recombinant polypeptides with improved purification
HK1008021A1 (en) Growth hormone receptor
ES2124295T3 (es) Expresion y purificacion de factor tisular soluble recombinante.
EP0759067A4 (en) TRANSFORMING GROWTH FACTOR ALPHA H1
ATE138102T1 (de) Verfahren zur herstellung von cysteinfreien peptiden
ES536027A0 (es) Un procedimiento para la produccion de un polipeptido
EP0269455A3 (en) Highly purified fused protein comprising human ige fc fragment and production thereof
EP0312358A3 (en) Method for promoting intramolecular disulfide bond formation in recombinant proteins contained in a denaturant solution
JPH02138980A (ja) 発現ベクターおよび該発現ベクターを使用してＣｒｏ／β−ガラクトシダーゼ／ＰＴＨ融合たん白質およびＰＴＨを取得する方法
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
AU7542187A (en) Light inducible promoter
EP0305063A3 (en) A process for production of c-terminal alpha-amide peptides
HUP9902550A2 (hu) Eljárások neuropátiás fájdalom prosaposinszármazék peptidekkel történő enyhítésére
HUP9902836A2 (hu) Eljárások az S-100 jelű agyi fehérje meghatározására

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20141228